Get the Stockscreener App
2.90
3.94%
0.11
After Hours:
2.90
Prime Medicine Inc Stock (PRME) Forecast
The Prime Medicine Inc (PRME) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.2223, representing a -23.37% decrease from the current price of $2.90. The highest analyst price target is $3.8608, and the lowest is $0.5839.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRME Price Target
Average 3.0558
(+5.37% Upside)
Is Prime Medicine Inc (PRME) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.76 | Neutral |
| STOCH(9,6) | 20.27 | Neutral |
| STOCHRSI(14) | 72.93 | Neutral |
| MACD(12,26) | -0.2058 | Sell |
| ADX(14) | 16.88 | Neutral |
| William %R | -63.83 | Neutral |
| CCI(14) | -54.62 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.973
Sell
|
2.945
Sell
|
| MA20 |
3.11
Sell
|
3.101
Sell
|
| MA50 |
3.5832
Sell
|
3.4467
Sell
|
| MA100 |
3.8005
Sell
|
3.9553
Sell
|
| MA200 |
4.9738
Sell
|
5.0237
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PRME could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on PRME, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.76 indicates that PRME is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.27 indicates that PRME is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.93 indicates that PRME is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.88 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -54.62 indicates that PRME is still oversold but not to an extreme extent.
Long-term PRME price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Prime Medicine Inc financial reports and earnings history, Prime Medicine Inc (PRME) stock could reach $15.34 by 2030, $77.06 by 2040 and $75.73 by 2050. See the projected annual prices until 2050 of the Prime Medicine Inc stock below:
- Prime Medicine Inc (PRME) is expected to reach an average price of $40.04 in 2035, with a high prediction of $40.45 and a low estimate of $40.84. This indicates an $1,281% rise from the last recorded price of $2.90.
- Prime Medicine Inc (PRME) stock is projected to chart a bullish course in 2040, with an average price target of $74.80, representing an $2,479% surge from its current level. The forecast ranges from a conservative $76.64 to a sky-high $77.06.
- Our analysts predict Prime Medicine Inc (PRME) to jump 1,547% by 2045, soaring from $48.27 to an average price of $47.77, potentially reaching $48.69. While $48.27 is the low estimate, the potential upside is significant.
- Prime Medicine Inc (PRME) stock is expected to climb by 2050, reaching an average of $74.90, a $2,483% jump from its current level. However, a wide range of estimates exists, with high and low targets of $75.73 and $74.98, respectively, highlighting the market's uncertainty.
Prime Medicine Inc Stock (PRME) Year by Year Forecast
Prime Medicine Inc Stock (PRME) Price Forecast for 2025
Prime Medicine Inc Stock (PRME) is expected to reach an average price of $3.0558 in 2025, with a high prediction of $6.0522 and a low estimate of $0.0594. This indicates an +5.37% rise from the last recorded price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.0258 | $0.5839 | $3.8608 | -30.15% |
| February, 2025 | $3.5166 | $1.3497 | $3.5666 | +21.26% |
| March, 2025 | $4.5525 | $2.8946 | $5.4925 | +56.98% |
| April, 2025 | $2.3373 | $2.1294 | $5.0104 | -19.40% |
| May, 2025 | $4.5432 | $2.3263 | $5.0832 | +56.66% |
| June, 2025 | $3.6191 | $3.0741 | $6.0522 | +24.80% |
| July, 2025 | $1.2639 | $1.0939 | $4.1081 | -56.42% |
| August, 2025 | $1.75 | $0.9229 | $2.5208 | -39.66% |
| September, 2025 | $0.1783 | $2.0183 | $1.3062 | -93.85% |
| October, 2025 | $0.9114 | $0.1955 | $2.1655 | -68.57% |
| November, 2025 | $1.9932 | $0.0594 | $4.6932 | -31.27% |
| December, 2025 | $3.0328 | $1.5874 | $3.2128 | +4.58% |
Prime Medicine Inc Stock (PRME) Price Forecast for 2026
The predicted value for Prime Medicine Inc (PRME) in 2026 is set at an average of $4.0091. Estimates vary from a peak of $7.9462 to a trough of $0.072, indicating an +38.25% surge from the present price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.2946 | $2.0546 | $4.1851 | -20.88% |
| February, 2026 | $2.2663 | $0.2004 | $2.9125 | -21.85% |
| March, 2026 | $0.5781 | $0.5222 | $2.6526 | -80.07% |
| April, 2026 | $4.3223 | $1.134 | $2.6623 | +49.04% |
| May, 2026 | $2.8405 | $3.1485 | $3.2743 | -2.05% |
| June, 2026 | $0.4688 | $1.2188 | $1.7446 | -83.83% |
| July, 2026 | $0.3891 | $0.072 | $1.185 | -86.58% |
| August, 2026 | $1.2974 | $1.6274 | $1.1674 | -55.26% |
| September, 2026 | $1.4223 | $0.1864 | $2.3344 | -50.95% |
| October, 2026 | $0.154 | $0.2539 | $1.7102 | -94.69% |
| November, 2026 | $1.9492 | $1.0001 | $1.0742 | -32.79% |
| December, 2026 | $8.4062 | $1.2883 | $7.9462 | +189.87% |
Prime Medicine Inc Stock (PRME) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Prime Medicine Inc (PRME) is $5.3033, with a high forecast of $8.1715 and a low forecast of $2.435. This indicates an +82.87% increase from the last price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.2286 | $7.1755 | $8.1493 | +114.78% |
| February, 2027 | $5.621 | $6.371 | $5.3579 | +93.83% |
| March, 2027 | $3.4065 | $4.1165 | $4.2241 | +17.46% |
| April, 2027 | $2.6888 | $3.2288 | $3.1527 | -7.28% |
| May, 2027 | $5.3012 | $2.435 | $2.7512 | +82.80% |
| June, 2027 | $4.7467 | $3.6136 | $4.1343 | +63.68% |
| July, 2027 | $6.5191 | $4.4711 | $5.7491 | +124.80% |
| August, 2027 | $8.2015 | $8.3353 | $8.1715 | +182.81% |
| September, 2027 | $6.547 | $7.047 | $6.7208 | +125.76% |
| October, 2027 | $3.8794 | $4.4467 | $5.5201 | +33.77% |
| November, 2027 | $5.8918 | $4.0725 | $4.8618 | +103.16% |
| December, 2027 | $3.0472 | $5.1672 | $5.2149 | +5.08% |
Prime Medicine Inc Stock (PRME) Price Forecast for 2028
In 2028, Prime Medicine Inc (PRME) is projected to reach an average price of $8.632, with a high projection of $14.99 and a low estimate of $2.2715. This indicates an +197.65% rise from the last price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.7196 | $2.2715 | $2.4703 | -6.22% |
| February, 2028 | $4.342 | $3.7358 | $3.1689 | +49.73% |
| March, 2028 | $4.2832 | $4.3051 | $4.2613 | +47.70% |
| April, 2028 | $15.39 | $15.79 | $14.99 | +430.77% |
| May, 2028 | $13.47 | $13.02 | $13.74 | +364.59% |
| June, 2028 | $9.1396 | $11.88 | $11.85 | +215.16% |
| July, 2028 | $9.6561 | $10.25 | $9.3778 | +232.97% |
| August, 2028 | $8.0567 | $8.2167 | $9.1702 | +177.82% |
| September, 2028 | $9.3932 | $9.3909 | $9.7391 | +223.90% |
| October, 2028 | $8.8998 | $9.0415 | $8.7706 | +206.89% |
| November, 2028 | $12.92 | $9.9739 | $12.21 | +345.53% |
| December, 2028 | $12.31 | $12.71 | $13.07 | +324.55% |
Prime Medicine Inc Stock (PRME) Price Forecast for 2029
The 2029 price forecast for Prime Medicine Inc Stock (PRME) is $13.88 on average, with a high prediction of $21.84 and a low estimate of $5.9304. This represents an +378.72% increase from the previous price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.4376 | $10.19 | $11.44 | +225.43% |
| February, 2029 | $8.0141 | $8.38 | $7.8417 | +176.35% |
| March, 2029 | $9.7006 | $8.8582 | $9.2865 | +234.50% |
| April, 2029 | $6.7871 | $7.3671 | $9.0747 | +134.04% |
| May, 2029 | $6.9978 | $5.9304 | $6.3378 | +141.30% |
| June, 2029 | $8.4743 | $7.1919 | $7.2643 | +192.22% |
| July, 2029 | $22.81 | $7.4267 | $20.48 | +686.55% |
| August, 2029 | $20.26 | $20.63 | $21.84 | +598.48% |
| September, 2029 | $18.56 | $19.63 | $19.47 | +539.88% |
| October, 2029 | $16.06 | $16.62 | $17.17 | +453.87% |
| November, 2029 | $14.84 | $15.52 | $15.35 | +411.82% |
| December, 2029 | $14.87 | $14.00 | $14.21 | +412.88% |
Prime Medicine Inc Stock (PRME) Price Forecast for 2030
Prime Medicine Inc Stock (PRME) is expected to reach an average price of $19.13 in 2030, with a high forecast of $28.68 and a low forecast of $9.5892. This signifies an +559.79% surge from the last price of $2.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.36 | $14.47 | $15.34 | +395.15% |
| February, 2030 | $16.42 | $15.09 | $14.85 | +466.21% |
| March, 2030 | $19.19 | $17.21 | $17.53 | +561.75% |
| April, 2030 | $17.00 | $17.49 | $17.97 | +486.25% |
| May, 2030 | $13.30 | $14.67 | $15.73 | +358.52% |
| June, 2030 | $12.96 | $12.69 | $12.06 | +346.82% |
| July, 2030 | $12.73 | $13.25 | $13.36 | +339.09% |
| August, 2030 | $9.5542 | $9.5892 | $10.62 | +229.46% |
| September, 2030 | $10.11 | $10.11 | $10.01 | +248.79% |
| October, 2030 | $10.72 | $10.92 | $10.64 | +269.68% |
| November, 2030 | $29.11 | $10.50 | $28.65 | +903.88% |
| December, 2030 | $26.23 | $27.35 | $28.68 | +804.39% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):